Should I start empiric treatment for spontaneous bacterial peritonitis (SBP) in a cirrhotic patient who has developed new ascites?

Empiric Treatment for SBP in New Ascites

You should NOT start empiric antibiotics for SBP solely based on the presence of new ascites—you must first perform a diagnostic paracentesis and document an ascitic fluid polymorphonuclear (PMN) count ≥250 cells/mm³ before initiating treatment. 1

Diagnostic Approach

Perform Paracentesis First

• Diagnostic paracentesis is mandatory in any cirrhotic patient with new ascites, worsening ascites, abdominal pain, fever, altered mental status, or any signs suggesting infection 1, 2
• Use ultrasound guidance to optimize the procedure 2
• Send ascitic fluid for:
  • Cell count with differential (PMN count is diagnostic)
  • Place fluid in blood culture bottles to improve culture yield 2
  • Consider leukocyte esterase reagent strips for rapid diagnosis if available 2

Diagnostic Criteria for SBP

• SBP is diagnosed when ascitic fluid PMN count is ≥250 cells/mm³ 1
• Some patients may be asymptomatic or have only mild symptoms 2
• Culture positivity is not required for diagnosis—many cases are culture-negative 1

When to Start Empiric Antibiotics

Start IV antibiotics immediately once PMN count ≥250 cells/mm³ is documented—do not wait for culture results 1

First-Line Antibiotic Selection

For community-acquired SBP:

• IV third-generation cephalosporin (cefotaxime 2g every 6-12 hours) is first-line therapy 1
• Achieves infection resolution in 77-98% of cases 1
• Duration: 5-7 days 1

For healthcare-associated, nosocomial SBP, or patients with:

• Recent broad-spectrum antibiotic exposure
• Sepsis or septic shock at presentation
• Use broad-spectrum antibiotics (carbapenem or piperacillin-tazobactam) as first-line 1, 3

Alternative options for uncomplicated SBP (without renal failure, hepatic encephalopathy, GI bleeding, ileus, or shock):

• Oral ofloxacin (400mg every 12 hours) 1
• Amoxicillin/clavulanic acid (IV then oral) 1
• Do NOT use quinolones if patient is already on quinolone prophylaxis, in areas with high quinolone resistance, or for nosocomial SBP 1

Critical Adjunctive Therapy

Add IV albumin in addition to antibiotics:

• 1.5 g/kg at day 1 and 1.0 g/kg at day 3 1
• Reduces mortality from 29% to 10% and prevents hepatorenal syndrome 1
• Patients with baseline creatinine ≥1.0 mg/dL, BUN ≥30 mg/dL, or bilirubin ≥4-5 mg/dL benefit most 1
• Even patients without these risk factors should receive albumin per current guidelines 1

Monitoring Response

• Repeat paracentesis at 48 hours after starting antibiotics to assess response 1
• Treatment failure is defined as <25% decrease in PMN count from baseline 1
• If treatment fails, broaden antibiotic coverage and investigate for secondary bacterial peritonitis with abdominal imaging 1

Common Pitfalls

• Do NOT treat empirically without paracentesis confirmation—new ascites alone does not warrant antibiotics
• Do NOT delay antibiotics once PMN ≥250 cells/mm³ is confirmed—mortality increases with delayed treatment 1
• Patients with PMN <250 cells/mm³ but positive culture (bacterascites) without symptoms should NOT receive antibiotics—repeat paracentesis instead 1
• Temporarily hold non-selective beta-blockers if patient develops hypotension (MAP <65 mmHg) or acute kidney injury 1